EMA Aims For Better Info On Benefit-Risk Balance To Support Drug Choices In Pregnancy
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
You may also be interested in...
A new EU guideline offers recommendations for facilitating appropriate pharmacovigilance for drugs that may be used in pregnant or breastfeeding women.
Draft guidance recommends complementary studies to evaluate effects of drug use during pregnancy; FDA may require lactation studies more frequently.
The UK Medicines and Healthcare products Regulatory Agency is developing a series of guidance documents on general points to consider when planning a trial to generate real-world evidence. The first document in this series focuses on prospective randomized trials.